Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.

NCT03088670 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

299

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Gosogliptin
DRUG: Vildagliptin
DRUG: Metformin

Sponsor

SatRx LLC